Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621257 · ClinicalTrials.gov registry record · NA
Vitamin D Levels in Children With IBD
A NA study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT00621257 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 134 participants.
The verdict
NCT00621257, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Research has shown that children with Inflammatory Bowel Disease may have lower levels of vitamin D than healthy children, especially in the winter. Vitamin D is important for growing and maintaining healthy bones throughout life, and this is particularly important, since children with IBD frequently have low bone density. It may also be helpful in the treatment of IBD itself, because it helps reduce inflammation. Vitamin D levels are measured by the amount of 25 OHD in the blood; however, measuring this level on a regular basis is not yet the standard for children with IBD. The purpose of this study is to find the best way to treat low vitamin D levels, and to maintain good vitamin D levels throughout the year. It will also test whether having higher vitamin D levels will improve the bone health of children with IBD, and whether it will help them have milder disease.
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- DIETARY_SUPPLEMENT ergocalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621257
The ClinicalTrials.gov registry entry for NCT00621257 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT00621257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00621257 about?
NCT00621257 is a clinical study titled "Vitamin D Levels in Children With IBD". Research has shown that children with Inflammatory Bowel Disease may have lower levels of vitamin D than healthy children, especially in the winter. Vitamin D is important for growing and maintaining healthy bones throughout life, and this is particularly important, since children with IBD frequentl...
What is the current status of trial NCT00621257?
This trial is currently terminated. It is a NA study. The enrollment target is 134 participants. The study started on 2008-01. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00621257?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), ergocalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00621257?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.